Síndrome de Rowell: las 2 caras de la verdad

López Caleya, Juan Francisco; Martín Rodrigo, Laura; Gonzalvo Rodriguez, Pablo; Hidalgo García, Yolanda.
Reumatol. clín. (Barc.) ; 12(6): 354-355, nov.-dic. 2016. ilus
Artículo en Español | IBECS (España) | ID: ibc-157442

Documentos relacionados

  1. Unilateral lupus mastitis.
  2. Combining maintenance therapy with hydroxychloroquine increases LLDAS achievement rates in individuals with stable systemic lupus erythematosus.
  3. Improvement in mucosal discoid lupus erythematosus with anifrolumab.
  4. Controversies in Systemic Lupus Erythematosus: Are We Treating Our Patients Adequately?
  5. Lupus erythematosus: Significance of dermatologic findings.
  6. Discoid drug-induced lupus erythematosus induced by antitumor necrosis factor agents is a very rare subtype of cutaneous lupus: Three cases and literature review.
  7. Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers.
  8. Time to progression from discoid lupus erythematosus to systemic lupus erythematosus: a retrospective cohort study.
  9. Assessing the quality of acne and rosacea treatment information on YouTube.
  10. Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.